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Eukaryotic initiation factor eIF2 is a key component of the ternary complex whose
role is to deliver initiator tRNA into the ribosome. A variety of stimuli, both physiologic
and pathophysiologic activate eIF2 kinases that phosphorylate the α subunit of eIF2,
preventing it from forming the ternary complex, thus attenuating cellular protein synthesis.
Paradoxically, in cancer cells, the phosphorylation of eIF2α is associated with activation
of survival pathways. This review explores the recently emerged novel mechanism of
eIF2α-independent translation initiation. This mechanism, which appears to be shared
by some RNA viruses and Internal Ribosome Entry Site-containing cellular mRNAs and
utilizes auxiliary proteins, such as eIF5B, eIF2D, andMCT-1, is responsible for the selective
translation of cancer-associated genes and could represent a weak point amenable to
specific targeting for the treatment of cancer.
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INTRODUCTION
Regulation of protein synthesis (translation) is a key cellular process, which underpins cellular
survival. Traditionally, the transcription and translation of the genome was considered to be a
highly correlated phenomenon, this notion has been challenged by the demonstration that mRNA
transcriptional outputs correlate with only about 40% of the total protein content in a cell (1,
2). This disconnect is further accentuated upon e.g., epidermal growth factor stimulation where
up to 90% of transcripts exhibited uncoupled translation from transcription (2). Interestingly,
these studies also showed that highly expressed transcripts are sometimes poorly translated and,
vice versa, poorly transcribed genes can be translated efficiently. This suggests that transcription and
translation are largely independent of each other, further strengthening the notion that translational
control has a major impact on regulating the proteome under certain conditions. It is therefore not
surprising that many aberrant cellular processes require modification of the translation machinery
and translation output (i.e., proteome). This is often the case in various stress responses and diseases
and is probably best exemplified in cancer. The link between misregulated translation and cancer
has long been suspected, and strong experimental evidence has been obtained by many laboratories
in recent years. This review will focus on one specific mechanism of translational dysregulation in
oncogenesis, which is the ability of cancer cells to utilize an eIF2α-independent mode of translation
initiation.
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eIF2 IS THE NEXUS THAT CONTROLS
TRANSLATION INITIATION EFFICIENCY
The eukaryotic initiation factor 2 (eIF2) is required for the for-
mation of the ternary complex [consisting of eIF2 (α, β, and
γ subunits), Met-tRNAi, and GTP], which in turn brings the
initiator Met-tRNAi to the P site of the 40S ribosomal subunit,
enabling initiation of protein synthesis. eIF2 exists in two distinct
configurations – the GDP- or GTP-bound forms. Following the
recognition of the start codon by the 43S preinitiation complex,
the GTP bound to eIF2 is hydrolyzed to deliver Met-tRNAi and
the eIF2. GDP is subsequently released from the 40S subunit to be
recycled for the delivery of another Met-tRNAi [reviewed in Ref.
(3)]. TheGDP toGTP exchange is catalyzed by the eIF2B (the gua-
nine exchange factor). This step is necessary for the regeneration
of active eIF2, which is the only form of eIF2 that can bind Met-
tRNAi. Regulation of the GDP–GTP exchange, thus, provides the
cell with a control point to match the protein synthesis rates to
the physiologic requirements (Figure 1). In response to virtually
all stresses, the α subunit of eIF2 is phosphorylated at serine 51,
FIGURE 1 | eIF2α is a control nexus integrating diverse stimuli to regulate translation. The eukaryotic initiation factor 2 (eIF2) is required for the formation of
the ternary complex [consisting of eIF2 (α, β, and γ subunits), Met-tRNAi, and GTP] whose role is to deliver the initiator Met-tRNAi to the P site of the 40S ribosomal
subunit, enabling translation initiation. eIF2 exists in two distinct configurations – the GDP bound (inactive) and GTP bound (active), but only the GTP-bound form can
bind Met-tRNAi. In response to diverse stress stimuli, distinct protein kinases phosphorylate the α subunit of eIF2 at serine 51, ultimately locking eIF2 in an inactive
eIF2 complex with eIF2B. As a result, availability of the ternary complex significantly declines ultimately resulting in the inhibition of translation globally. Selective
translation of a subset of mRNAs with uORFs continues, however, allowing cells to express proteins required for adaptation to stress conditions.
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which greatly increases its avidity for eIF2B and locks both pro-
teins in an inactive eIF2–eIF2B complex. Since eIF2B is present in
limiting concentrations, phosphorylation of even a small fraction
of eIF2α is sufficient to inhibit its recycling. As a result, availability
of the ternary complex significantly declines leading to inhibition
of 43S formation and attenuation of translation initiation (4).
In mammalian cells, there are four eIF2α kinases that integrate
a variety of distinct stresses to phosphorylate eIF2α. Thus, haem-
regulated inhibitor (HRI) is activated by iron deficiency (5), heavy
metals (6), osmotic, or oxidative stress and heat shock (7); protein
kinase activated by double-stranded RNA (PKR) is activated by
dsRNA during viral infection (8) or interferon-induced apoptosis
(9); general control non-derepressible-2 (GCN2) is activated by
amino acid starvation (10) and UV irradiation (11); and PKR-like
endoplasmic reticulum kinase (PERK) is activated in response to
endoplasmic reticulum (ER) stress (12) and UV irradiation (13).
Since the ternary complex is absolutely required for the translation
of cellular mRNAs, the phosphorylation of eIF2α is expected to
inhibit translation globally. However, for certain mRNAs, phos-
phorylation of eIF2α enhances their translation. These mRNAs
frequently encode for proteins required for stress adaptation and
recovery [reviewed in Ref. (14)]. These mRNAs, best exemplified
by the transcription factor ATF4, contain short upstream ORFs
(uORFs) in their 50 untranslated regions (UTRs) that engage the
ribosome and thus cause the main coding ORF of these mRNAs
to be poorly translated when ternary complex is abundant. In
contrast, during stress conditions when the abundance of ternary
complex is limited, some ribosomes pass through the uORFs
without initiating until they acquire a ternary complex upstream
of the main coding ORF, resulting in productive translation of the
main ORF. It is expected, however, that under conditions of severe
stress if no ternary complex is available even translation of these
mRNAs would be inhibited.
EVIDENCE FOR eIF2α-INDEPENDENT
TRANSLATION
In the last decade or so, evidence has begun to emerge pointing to
the existence of an eIF2α-independent initiation of translation. It
was observed in several independent studies that phosphorylation
of eIF2α is frequently required to promote cell survival under
various stresses, but the genes lying downstream of eIF2α regu-
lation did not necessarily utilized the uORF-dependent mecha-
nism. For example, following nutritional stress caused by amino
acid starvation, induction of amino acid transporter SNAT2, a
component of transport system A, which is required to promote
recovery of amino acid balance, was blunted in cells unable to
phosphorylate eIF2α (15). Similarly, translation of the inhibitor
of apoptosis proteins XIAP and cIAP1 was shown to be resistant
to the global attenuation of translation due to eIF2α phospho-
rylation during hypoxia (16, 17), glucose deficiency (18), serum
deprivation (19–21), or ER stress (22). Other examples of mRNAs
whose translation is enhanced by eIF2α phosphorylation include
VEGF and p120 catenin [observed in hypoxic inflammatory
breast tumors (23, 24)], Bcl-xL [during hypertonic stress (25)], or
c-Src and c-myc [during ER stress (26, 27)]. Interestingly, none of
these mRNAs harbor uORFs that would enable enhanced mRNA
translation under conditions of reduced ternary complex avail-
ability. Instead, Internal Ribosome Entry Site (IRES) sequences
were described in the 50 UTRs of these mRNAs. IRESs are discrete
functional RNAmotifs that support translation of the downstream
reading frame by an alternative mechanism that does not appear
to rely on m7G cap structure or initiation factors that recognize
the cap. This phenomenon, termed internal initiation, was first
observed in RNA viruses (in particular Picornaviridae) whose
RNA is naturally uncapped, and yet, it is efficiently translated
by the host translation machinery (28). Instead of cap, IRESs
precede the protein-coding portion of the viral RNA and directly
recruit the 40S ribosome to the vicinity of initiation codon. The
recruitment of the 40S can occur either in the complete absence
of any other protein factors (dicistrovirus intergenic IRES) or with
the aid of various combinations of canonical initiation factors
(such as eIF4G and eIF3) and auxiliary proteins in case of the
remaining viral IRES [reviewed in Ref. (29)].
Similarly to the internal initiation in viruses, some cellular
mRNAs were shown to be translated by this alternative mode of
translation. It was observed that a subset of cellular mRNAs (up
to 5%) was efficiently translated in cells infected with poliovirus
which cleaves eIF4G and thus inhibits cap-dependent translation
(30). Follow-up studies identified functional IRES in a variety of
cellular mRNAs, and many cellular IRES elements were shown to
be bona fide regulatory elements that direct translation of their
respective proteins in a cap- and/or eIF4E-independent manner
during various cellular stresses or pathological conditions, such
as tumorigenesis, in particular. It is, therefore, not surprising
that many of the IRES-harboring mRNAs encode proteins that
are key regulators of cell proliferation and survival/apoptosis and
their misregulated expression is frequently associated with cancer.
Thus, we and others have proposed that the selective regulation
of IRES-mediated translation is important for the regulation of
cell death and survival (14, 31–34). Indeed, the experimental
data from many laboratories have now validated this hypothesis
in a number of models [reviewed in Ref. (34, 35)]. The in vivo
evidence supporting this concept, and particularly in the context
of cancer formation, is particularly striking. For example, the
selective impairment of IRES-mediated translation but not cap-
dependent translation is correlated with enhanced apoptosis of
hematopoietic progenitors and stem cells, leading to the fatal
progressive bone marrow failure syndrome known as dyskeratosis
congenita and its associated tumorigenesis (36–38). A switch to
IRES-dependent translation has been implicated in breast cancer
growth and angiogenic potential in vivo (39), and in the acquired
resistance of cancer cells to radiation-induced apoptosis (40).
Similarly, HPV-induced transformation of human keratinocytes is
accompanied by a switch from cap-dependent to IRES-dependent
translation (41).
MECHANISMS OF eIF2α-INDEPENDENT
TRANSLATION
The mechanism of how translation initiation can occur without
the eIF2was first described in viruses that utilize IRESmechanism
of translation initiation, and whose translation has been reported
to be refractory to reduced availability of ternary complex. The
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simplest model is the CrPV virus, in which the secondary and ter-
tiary structures of the intergenic region IRES mimic the function
of a peptidyl tRNA (Met-tRNAi) in the P site, recruit 40S and 60S
ribosomal subunits to form 80S, and direct the synthesis of viral
polyprotein by inducing ribosomal translocation (42). Hepatitis
C virus (HCV) and classical swine fewer virus (CSFV) were both
shown to use eIF5B instead of eIF2 to deliver initiator tRNA into
the P site of the ribosome (43–45). The canonical role of eIF5B
is in ribosome subunit joining, and it does not normally promote
binding of initiator tRNA to the 40S subunit. However, it appears
to “take over” when eIF2 is inactivated due to phosphorylation.
In addition to eIF5B, other cellular proteins including eIF2D
(formerly called Ligatin) and MCT-1/DENR were all reported to
be able to deliver tRNA into the P site of the ribosome during
HCV IRES-mediated translation (46, 47). Their role in supporting
cellular mRNA translation during stress has not yet been fully
elucidated.
Evidence is starting to emerge that a similar eIF5B-dependent
mechanism operates on cellular mRNAs as well. We have inves-
tigated the molecular mechanism of eIF2α-independent trans-
lation of XIAP mRNA (21). XIAP protein is encoded by two
mRNA splice variants that differ only in their 50 UTR regions.
The more abundant, shorter transcript produces the majority of
XIAP protein under normal growth conditions by cap-dependent
translation. However, during cellular stress, the longer transcript,
containing the IRES element, directs efficient translation despite
attenuation of global, cap-dependent translation (20). During
normal proliferative conditions, when the ternary complex is
available in abundance, XIAP translation continues in an eIF2α-
dependent mode, similar to other cellular mRNAs. However,
upon serum deprivation, the XIAP IRES-dependent translation
switches to an alternative, eIF5B-dependent mode to circumvent
attenuation due to eIF2α phosphorylation. The ability of the
cell to evade ternary complex requirement suggests that cells
have evolved an alternative, eIF2α-independent mechanism of
tRNA delivery to support a “rescue” mechanism of translation
of critical survival proteins under conditions when the “normal”
mechanism is not available. Interestingly, a limited investigation
of other cellular IRES-containing mRNAs (Bcl-xL, cIAP1, Apaf-1,
and p97/DAP5) suggests that not all cellular IRESs utilize eIF5B-
dependentmode of tRNAdelivery during serum deprivation (21).
However, the full spectrum of eIF5B-dependent cellular mRNA
transcripts still needs to be determined.
Multiple copies in T-cell lymphoma-1 (MCT-1; also called
MCST1, malignant T-cell amplified sequence 1) is an oncogene,
which is also implicated in the regulation of cellular mRNA
translation, although the precise mechanism of this control is
not clear (48). MCT-1 recruits DENR (density regulated pro-
tein) to aid in the post-termination ribosome recycling (49). In
addition, DENR/MCT-1 complex interacts with the cap com-
plex and enhances translation of a subset of mRNAs whose
products are involved in the regulation of apoptosis and the
cell cycle. Of note, some of these mRNAs, such as cyclin D1,
HSP70, and cIAP1, were previously reported to be translated
by an IRES-dependent mechanism (22, 50, 51). Recently, a
different cohort of specific mRNAs that require DENR/MCT-
1 complex for efficient translation was identified by polysome
profiling experiments in DENR-knockdownDrosophila cells (48).
Interestingly, these mRNAs, enriched for transcriptional regu-
lators and oncogenic kinases, were characterized by the pres-
ence of uORFs with strong Kozak sequence. However, further
experiments revealed that DENR/MCT-1 promotes reinitiation
of translation on these mRNAs, so the mechanism of transla-
tion upregulation by DENR/MCT-1 is distinct from the classical
uORF-dependent mode that is used by ATF4. Whether or not
DENR/MCT-1 can also function in an alternative ternary complex
formation in order to deliver initiator tRNA under conditions of
cell stress has not been tested.
eIF2α-INDEPENDENT TRANSLATION AND
CANCER
Phosphorylation of eIF2α serves to integrate diverse stress sig-
nals, both intra- and extracellular, and for both physiologic and
pathophysiologic conditions. The role of eIF2α in tumorigene-
sis has been recently summarized (3). Studies in mouse models
and human tumors suggest that targeted disruption of eIF2α
phosphorylation could be exploited to increase the efficacy of
therapeutic intervention. In addition, initiation of apoptosis (the
main mechanism of action of chemotheraphy drugs) results in
the caspase-mediated cleavage of eIF2α (52–54), suggesting that
inhibition of the ternary complex formation may be part of the
translational reprograming accompanying apoptosis.
It is, therefore, important to explore the possibility that tumor
cells could gain a selective growth advantage and evade apoptosis
by utilizing an eIF2α-independent mode of translation initia-
tion of cancer-related mRNAs, such as XIAP, cIAP1, cyclin D1,
and others. As noted above, MCT-1 is an oncogene involved in
the regulation of cell cycle and apoptosis. Expression of MCT-1
transforms NIH3T3 and MCF-10A cells (55, 56) and promotes
aggressive growth, angiogenesis, tissue invasiveness, and inhibi-
tion of apoptosis in breast (57) and lymphoma (58) tumormodels.
Furthermore, high expression of MCT-1 was reported in 83.9%
of human lung carcionomas (59). MCT-1 acts in conjunction
with DENR; however, there is no information available on the
expression and role of DENR in tumorigenesis yet. A quick survey
of the antibody staining data in TheHumanProteinAtlas1 showed
that DENR is detected in 74% of the cancers, but the discordantly
high expression relative to normal tissue is most noticeable in
gliomas, lymphomas, melanoma, skin, and urothelial cancers. Of
note, expression of MCT-1 is also particularly high in glioma,
melanoma, and urothelial cancers (see text footnote 1), suggesting
that the concomitant expression of DENR and MCT-1 in these
particular cancers may lead to translational activation of specific
mRNAs. This notion, however, awaits experimental validation.
There is no available literature on the possible involvement of
eIF2D in cancer with the exception of eIF2D being identified as
a hepatocellular carcinoma (HCC) – associated antigen in a study
of four HCC patients (60). A survey of The Human Protein Atlas
shows increased expression in some head and neck, lymphoma,
melanoma, ovarian, pancreatic, stomach, and urothelial cancers
1http://www.proteinatlas.org
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FIGURE 2 | eIF2α-independent translation in cancer. Cancer environment, such as hypoxia, growth factor and cytokine signaling, and various forms of stress,
leads to enhanced phosphorylation or proteolytic degradation of eIF2α which causes attenuation of protein synthesis due to unavailability of the ternary complex
(right). However, this allows Met-tRNAi to form an alternative ternary complex with proteins like eIF5B, eIF2D, and DENR/MCT-1 (left). Alternative ternary complex
supports translation of select mRNAs, including those regulating apoptosis and cell cycle progression, in an eIF2α-independent manner, ultimately providing the
cancer cell with a survival advantage. Specific targeting of the eIF2α-independent translation mechanism therefore offers a possible therapeutic target to treat cancer.
(see text footnote 1). Interestingly, eIF2D belongs to a family of
PUA (pseudouridine synthase and archaeosine transglycosylase)
domain containing proteins, along with DENR and MCT-1 (61).
Another notablemember of this family is dyskerin (DKC1), which
has been shown to play a key role in enabling translation of cancer-
related IRES-containing mRNAs, such as Bcl-xL, XIAP (36), p27
(38), and p53 (37). DKC1 deficiency results in the decrease in
modification of ribosomal RNA uridines, which consequently
renders the ribosome unable to efficiently engage select mRNAs
for translation (62). An intriguing possibility, which ought to
be experimentally investigated is whether, like DENR/MCT-1
or eIF2D, DKC1 can also participate in the formation of an
alternative ternary complex for these mRNAs.
eIF5B was shown to control cell cycle transition and devel-
opmental stages during oocytes maturation, by inhibiting cell
cycle arrest (63). Interestingly, this study also demonstrated that
both the levels of eIF5B and the association of eIF5B with Met-
tRNAi were increased during serum starvation of oocytes, ES cells,
or in proliferating T cells. This was accompanied by increased
phosphorylation of eIF2α, suggesting that under these conditions
eIF5B may preferentially enhance translation of specific mRNAs.
In addition, depletion of eIF5B impaired translation in mature,
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but not proliferating cells, further supporting a stage-specific role
for eIF5B. Given the essential role of eIF5B in general transla-
tion, it is expressed in all normal tissues; however, there is an
enhanced expression in some melanoma and ovarian cancers (see
text footnote 1). Of note, the majority of the surveyed cancers
show reduced eIF5B staining, when compared to the expression
of eIF5B in normal tissues, suggesting that a relationship between
eIF5B and tumorigenesis is likely not straightforward.
FUTURE PERSPECTIVES
Over the past two decades, eIF2α has emerged as a critical nexus
integrating diverse cellular and extracellular signals to control
protein synthesis. More recently, the evidence is mounting to
link eIF2α phosphorylation to tumorigenesis [reviewed in Ref.
(3)]. In particular, elevated levels of eIF2α phosphorylation were
shown to correlate with cancer cell survival. These observations
are somewhat paradoxical, since cancer cells typically display ele-
vated protein synthesis levels (64), which would not be compatible
with elevated levels of eIF2α phosphorylation. Phosphorylation
of eIF2α, therefore, likely serves to activate specific survival path-
ways, some of which may rely on the formation of an alternative,
eIF2α-independent ternary complexes to promote translation of
cancer-specific mRNAs (Figure 2). These alternative pathways
and their components, such as eIF5B, eIF2D, and DENR/MCT-
1, could, therefore, represent as of yet unexplored Achilles heels
of cancer. For example, we have shown that eIF5B promotes
IRES-dependent translation of an inhibitor of apoptosis XIAP
(21). Chemoresistance in several types of cancer cells has been
associated with increased expression of XIAP (65–69). Impor-
tantly, XIAP has been validated as a potent therapeutic target, and
various anti-XIAP strategies for cancer treatment are currently
being tested in clinical trials (70). As with many other tumor-
specific targets, the specificity of the therapeutics intervention for
tumor cells is desirable, since XIAP deficiency in non-cancerous
cells can lead to disorders, such as X-linked lymphoprolifera-
tive disease (71, 72). Specific targeting of the eIF2α-independent
mode of translation ofXIAP andother cancer-relatedmRNAsmay
provide this needed specificity.
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